Cumberland Pharmaceuticals (CPIX) EBIT Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 273.62% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.84% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 4.63% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 31.70% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 54.58% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 40.87% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -63.87% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 120.38% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -90.87% |
| 10 | Cumberland Pharmaceuticals | 87.59 Mn | 76.25 Mn | 7.20 Mn | -26.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.89% |
| Dec 31, 2025 | 15.56% |
| Sep 30, 2025 | -89.55% |
| Jun 30, 2025 | 26.03% |
| Mar 31, 2025 | 44.22% |
| Dec 31, 2024 | 24.93% |
| Sep 30, 2024 | -2.72% |
| Jun 30, 2024 | 10.58% |
| Mar 31, 2024 | -79.30% |
| Dec 31, 2023 | -52.39% |
| Sep 30, 2023 | -15.59% |
| Jun 30, 2023 | 26.29% |
| Mar 31, 2023 | 6.03% |
| Dec 31, 2022 | 12.45% |
| Sep 30, 2022 | 55.14% |
| Jun 30, 2022 | -10.37% |
| Mar 31, 2022 | 0.81% |
| Dec 31, 2021 | -24.38% |
| Sep 30, 2021 | 4.71% |
| Jun 30, 2021 | -18.22% |